Skip to main content

previous disabled Page of 210
and
  1. Article

    Open Access

    Correction: MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma

    Qin Tang, Wan Li, **ang** Zheng, Liwen Ren in Signal Transduction and Targeted Therapy (2024)

  2. Article

    Open Access

    Carbon-ion radiotherapy alone vs. standard dose photon radiation with carbon-ion radiotherapy boost for high-grade gliomas: a retrospective study

    This study aimed to compare the survival outcome and side effects in patients with primary high-grade glioma (HGG) who received carbon ion radiotherapy (CIRT) alone or as a boost strategy after photon radiatio...

    **aoJun Li, YanShan Zhang, YanCheng Ye, SuQing Tian, TingChao Hu, HongYu Chai in BMC Cancer (2024)

  3. Article

    Open Access

    Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study

    This study aimed to investigate the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) for primary prophylaxis of neutropenia in patients with cervical cance...

    **g You, Yidi Yuan, **aoxuan Gu, Weihu Wang, **aofan Li in BMC Cancer (2024)

  4. Article

    Open Access

    Nomogram for predicting the probability of rectal anastomotic re-leakage after stoma closure: a retrospective study

    In this study, we aimed to identify the risk factors in patients with rectal anastomotic re-leakage and develop a prediction model to predict the probability of rectal anastomotic re-leakage after stoma closure.

    Yuegang Li, Gang Hu, **zhu Zhang, Wenlong Qiu, Shiwen Mei, **shan Wang in BMC Cancer (2024)

  5. Article

    Open Access

    Synergistic induction of mitotic pyroptosis and tumor remission by inhibiting proteasome and WEE family kinases

    Mitotic catastrophe (MC), which occurs under dysregulated mitosis, represents a fascinating tactic to specifically eradicate tumor cells. Whether pyroptosis can be a death form of MC remains unknown. Proteasom...

    Zhan-Li Chen, Chen **e, Wei Zeng, Rui-Qi Huang in Signal Transduction and Targeted Therapy (2024)

  6. Article

    Open Access

    eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma

    Extracellular heat shock protein 90 AA1(eHSP90α) is intricately linked to tumor progression and prognosis. This study aimed to investigate the difference in the value of eHSP90α in post-treatment response asse...

    Yingzhen Bian, Haizhou Liu, **glei Huang, Zhaorong Feng, Yanyan Lin in BMC Cancer (2024)

  7. Article

    Open Access

    Correction: Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy

    Yu-An Li, Chuan Zhao, **g-**g Ge, Cheng Li, Feng-Jun Xue, Shao-Pei Qi in BMC Cancer (2024)

  8. Article

    Open Access

    Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

    Most gastrointestinal stromal tumors (GISTs) harbor c-KIT or PDGFRA mutations. Administration of tyrosine kinase inhibitors (TKIs) has significantly improved the survival of patients with GISTs. We aimed to evalu...

    Hui-Jen Tsai, Yan-Shen Shan, Ching-Yao Yang, Chin-Fu Hsiao, Chung-Hsin Tsai in BMC Cancer (2024)

  9. Article

    Open Access

    Genetic constraint at single amino acid resolution in protein domains improves missense variant prioritisation and gene discovery

    One of the major hurdles in clinical genetics is interpreting the clinical consequences associated with germline missense variants in humans. Recent significant advances have leveraged natural variation observ...

    **aolei Zhang, Pantazis I. Theotokis, Nicholas Li, Caroline F. Wright in Genome Medicine (2024)

  10. Article

    Open Access

    Selective anti-tumor activity of glutathione-responsive abasic site trap** agent in anaplastic thyroid carcinoma

    Anaplastic thyroid carcinoma (ATC) is a rare but highly aggressive thyroid cancer with poor prognosis. Killing cancer cells by inducing DNA damage or blockage of DNA repair is a promising strategy for chemothe...

    **yan Chai, Mengxue Su, Ruiguo Zhang, Ning Li, Yuanyuan Jia, Wei Zheng in BMC Cancer (2024)

  11. Article

    Open Access

    Prognostic and clinicopathological significance of tertiary lymphoid structure in non-small cell lung cancer: a systematic review and meta-analysis

    Non-small cell lung cancer (NSCLC) is the primary reason for cancer-related deaths globally. Tertiary lymphoid structure (TLS) is an organized collection of immune cells acquired in non-physiological, non-lymp...

    Luyuan Ma, Rongyang Li, **aomeng Liu, Wenhao Yu, Zhanpeng Tang, Yi Shen in BMC Cancer (2024)

  12. Article

    Open Access

    KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer

    There is mounting evidence that patients with liver cancer can benefit from Immune checkpoint inhibitors. However, due to the high cost and low efficacy, we aimed to explore new biomarkers for predicting the e...

    Sihui Zhu, Yuncheng **, Mingzhen Zhou, Lin Li, Xueru Song, **nyu Su in BMC Cancer (2024)

  13. Article

    Open Access

    Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1

    Drug resistance remains a significant challenge in the treatment of pancreatic cancer. The development of drug-resistant cell lines is crucial to understanding the underlying mechanisms of resistance and devel...

    Cheng Yu, Yuanhui Su, **n Miao, Changpeng Chai, Huan Tang, Lu Li, Jianfeng Yi in BMC Cancer (2024)

  14. Article

    Open Access

    Integrating lipid metabolite analysis with MRI-based transformer and radiomics for early and late stage prediction of oral squamous cell carcinoma

    Oral Squamous Cell Carcinoma (OSCC) presents significant diagnostic challenges in its early and late stages. This study aims to utilize preoperative MRI and biochemical indicators of OSCC patients to predict t...

    Wen Li, Yang Li, Shiyu Gao, Nengwen Huang, Ikuho Kojima, Taro Kusama in BMC Cancer (2024)

  15. Article

    Open Access

    Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy

    Patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) have proven benefit from anti-programmed cell death 1 (anti-PD-1) monotherapy. Here, we retrospectively analyze the association of plasma...

    Shaoyan Lin, Huaqiang Zhou, Gang Chen, **hui Xue, Qianwen Liu, Jianing Li in BMC Cancer (2024)

  16. No Access

    Article

    Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma

    The clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma (ND-DLBCL) remains largely unexplored. One hundred ND-DLBCL patients were consecutively enrolled as training c...

    **-Hua Liang, Yi-Fan Wu, Hao-Rui Shen, Yue Li, Jun-Heng Liang, Rui Gao in Leukemia (2024)

  17. Article

    Open Access

    Combination of MRI-based prediction and CRISPR/Cas12a-based detection for IDH genoty** in glioma

    Early identification of IDH mutation status is of great significance in clinical therapeutic decision-making in the treatment of glioma. We demonstrate a technological solution to improve the accuracy and reli...

    Donghu Yu, Qisheng Zhong, Yilei **ao, Zhebin Feng, Feng Tang in npj Precision Oncology (2024)

  18. No Access

    Article

    Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition

    Internal tandem duplication mutations of FLT3 (FLT3/ITD) confer poor prognosis in AML. FLT3 tyrosine kinase inhibitors (TKIs) alone have limited and transient clinical efficacy thus calling for new targets for...

    Ruiqi Zhu, Courtney M. Shirley, S. Haihua Chu, Li Li, Bao H. Nguyen in Leukemia (2024)

  19. Article

    Open Access

    B cell lymphoma 6 promotes hepatocellular carcinoma progression by inhibiting tumor infiltrating CD4+T cell cytotoxicity through ESM1

    Immunotherapy exhibited potential effects for advanced hepatocellular carcinoma, unfortunately, the clinical benefits are often countered by cancer adaptive immune suppressive response. Uncovering the mechanis...

    Jiatao Li, Juan Feng, Ziyong Li, Yuanli Ni, Limei Liu, **a Lei in npj Precision Oncology (2024)

  20. No Access

    Article

    Increased coexpression of PD-L1 and IDO1 is associated with poor overall survival in patients with NK/T-cell lymphoma

    Immunotherapy with programmed cell death 1 ligand 1 (PD-L1) blockade was effective in patients with NK/T-cell lymphoma. In addition to PD-L1, indoleamine 2,3-dioxygenase-1 (IDO1) is one of the most promising i...

    Yajun Li, Kailin Chen, Bihua Chen, Ruolan Zeng, Yizi He, Caiqin Wang in Leukemia (2024)

previous disabled Page of 210